Search results
FDA Head Questioned on Zantac’s Hidden Cancer Risk by Top Democrat DeLauro
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- The Food and Drug Administration’s chief is facing questions from a top lawmaker...
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
USA TODAY via Yahoo News· 1 year agoFor people managing high blood pressure, recalls of the carcinogen-tainted drug quinapril might...
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
Investor's Business Daily· 2 years agoPharmaceutical stocks GSK, Sanofi and Haleon have wiped out a combined $31 billion in market cap...
Sanofi to settle 4,000 lawsuits claiming Zantac is linked to cancer
Scripps News via AOL· 2 months agoA box of Maximum Strength Zantac tablets at a pharmacy The French pharmaceutical company Sanofi says...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
Reuters via AOL· 1 month ago(Reuters) -GSK has been sued by an independent Connecticut laboratory that accused the drugmaker of...
GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023
Benzinga via Yahoo Finance· 1 year agoThe first scheduled trial expected next week, related to GSK Plc's (NYSE: GSK) Zantac associated...
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
GSK soothes investors by settling first Zantac cancer lawsuit due for US trial
Reuters via Yahoo Finance· 12 months agoGSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug Zantac caused cancer,...
First Zantac cancer risk trial in Calif. postponed five months
Reuters via Yahoo News· 1 year ago(Reuters) -The first scheduled trial over claims that GSK Plc's heartburn drug Zantac caused cancer,...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoMonday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE), following a Delaware judge’s ruling on 31 May that more...